Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor
Authors
- Noritaka Honda
- Hiroshi Mukae (ORCID: https://orcid.org/0000-0002-1429-5706)
- Yasushi Obase (ORCID: https://orcid.org/0000-0001-8838-7403)
- Takahiro Takazono (ORCID: https://orcid.org/0000-0002-0696-5386)
- Shinnosuke Takemoto (ORCID: https://orcid.org/0000-0003-0373-0618)
- H. Gyotoku
- Takeo NISHINO (ORCID: https://orcid.org/0009-0004-3635-609X)
- Noriho Sakamoto (ORCID: https://orcid.org/0000-0002-7577-476X)
- Hiroshi Ishimoto (ORCID: https://orcid.org/0000-0002-4374-2894)
- Fumiko Hayashi
- H. Taniguchi
- Erika Imamura
- Mitsuko Masutani (ORCID: https://orcid.org/0000-0003-2631-4334)
- Sawana Ono
Institutions
- Nagasaki University Hospital (JP)
- Nagasaki University (JP)